This study is for people with a type of eye problem called neovascular age-related macular degeneration (nAMD). This condition causes new blood vessels to grow in the eye, which can lead to vision loss. The study is testing a new treatment called zifibancimig, which is given through injections directly into the eye. The study will check if the treatment is safe and if it helps improve or stabilize vision.

Participants must have specific eye conditions related to nAMD and meet other health criteria. Some people won’t qualify, like those who had certain eye surgeries or other eye diseases. The study involves collecting samples from the eye and requires several visits to the research center.

• The study involves multiple visits for eye exams and sample collections.
• Participants must have nAMD and meet specific health criteria.
• The study will check if the treatment is safe and works well.